What Is STI Testing and How It Works in the UK

You've had sex with a new partner, feel perfectly well, and are now wondering whether ordering an STI test would be sensible. Or perhaps you've noticed a change, but you're unsure whether it's an infection, irritation, or something unrelated. These questions are common, and what STI testing means in practice is simpler than it can sound: a test checks a carefully collected sample for signs of a sexually transmitted infection.

Testing isn't reserved for people with symptoms. In England, sexual health services recorded 2,367,853 sexual health screens in 2024, following 2,195,909 in 2022 and 2,380,498 in 2023, showing that testing is a routine part of public health rather than a niche service (UKHSA's latest STI data). In 2025, the annual report counted 8,903,930 STI tests in England, and 70.3% were carried out in people without symptoms (UKHSA's 2025 STI report).

That matters because an infection can be present without obvious signs. Testing can provide reassurance, identify an infection early, and help you access treatment or notify partners before transmission continues. If symptoms are severe, worsening, or accompanied by significant pain, seek clinical advice rather than relying only on an at-home kit.

For a broader explanation of the checks included in sexual health care, you can read this guide to sexual health screening. The important point is that the right test depends on your exposure, symptoms, body site, and the time since possible contact.

Introduction to What STI Testing Means Today

STI testing is a process of collecting urine, a swab, or blood, then sending that sample for a laboratory test designed to look for a particular infection. The result may be negative, positive, or require further confirmation. It isn't a single universal test, and there isn't one sample that detects every STI.

Testing has become an established part of sexual health monitoring in England. UKHSA's surveillance framework has been publishing official annual STI statistics since 17 June 2010, tracking diagnoses by infection type, region, and demographic group (UKHSA annual STI statistics). The figures also show why routine testing matters. In 2024, England recorded 364,750 STI diagnoses, a 9% fall from 2023, while diagnoses still remained substantial (UKHSA's latest STI data).

Testing isn't a judgement

A test doesn't say anything about someone's character, relationship, or sexual behaviour. It answers a medical question: is there evidence of this infection in the sample collected at this point in time?

Someone might test after a new partner, before stopping condom use, after a partner receives a diagnosis, or as part of regular screening. Someone else might test because of discharge, pain when urinating, sores, or a rash. Both are valid reasons, but symptoms alone can't reliably identify the cause.

You might also test with no symptoms because many infections can be silent. The 2025 English data show that asymptomatic testing is not an unusual edge case. It's a central reason people use sexual health services.

What the process usually involves

The pathway is generally straightforward:

• Choose the relevant infections: A clinician or test provider considers your exposure and risk rather than automatically adding every available test.
• Provide the correct sample: This may be first-catch urine, a genital, throat, or rectal swab, or blood.
• Allow the laboratory to process it: The laboratory uses a method suited to the infection being investigated.
• Read the result securely: Follow-up may include treatment, partner notification, repeat testing, or clinical review.

The rest of this guide focuses on matching the sample to the infection, understanding window periods, and deciding whether an at-home kit or clinic pathway is more appropriate.

How STI Testing Works in Simple Terms

Think of the sample as a message from a specific part of your body. The laboratory needs the right message, collected from the right place, using a method designed to recognise the infection.

For chlamydia and gonorrhoea, UK testing commonly uses nucleic acid amplification tests, or NAATs. These tests look for genetic material from the bacteria. A simple analogy is a lock and key. The test contains a carefully selected target, and if the matching genetic sequence is present, the laboratory can detect it.

Blood tests work differently. They can look for immune responses, such as antibodies, or other markers associated with an infection. That's why blood is generally used for infections such as HIV and syphilis, while urine or swabs are commonly used for chlamydia and gonorrhoea.

Screening and diagnostic testing

Screening is testing when you may feel well and want to check for an infection. Diagnostic testing is used when symptoms, a known exposure, or a partner's result makes a particular infection more likely.

The laboratory method may be similar, but the context changes what happens next. A person with a positive partner notification may need prompt clinical guidance even if their first sample is taken early. Someone with symptoms may need examination and additional swabs rather than relying on a standard urine screen.

A standard panel also doesn't cover every possible condition. A provider might recommend a narrower set of tests for someone with lower risk, while adding hepatitis B or C when relevant risk factors are present. The sample must reflect the sites involved in sexual contact, too. A urine sample won't necessarily answer a question about an infection in the throat or rectum.

From collection to result

At-home testing follows the same basic logic as clinic testing. You collect the sample according to the instructions, label it correctly, place it in the supplied packaging, and return it to the laboratory. Repose Healthcare's at-home kits include clear instructions and prepaid return packaging, with samples processed in UK-accredited laboratories and results typically delivered through a secure, GDPR-compliant dashboard within 1 to 3 working days, according to the provider information.

Practical rule: A test can only answer the question asked by its method and sample. “I tested” isn't enough on its own. You also need to know which infection, which body site, and when the sample was taken.

If a result is reactive or positive, the laboratory or healthcare service may use additional testing before confirming the diagnosis. This is particularly important for tests where an initial screen can produce a result that needs further investigation.

Types of STI Tests and Which Sample You Need

The most useful way to choose a test is to start with the infection and exposure site, then select the sample. A urine test, swab, and blood test aren't interchangeable.

For chlamydia and gonorrhoea, UK guidance recommends first-catch urine for men or people with a penis. For women or people with a vagina, vulvovaginal swabs are recommended, because urine isn't considered suitable for optimal detection in this context (UK SMI guidance on chlamydia and gonorrhoea NAATs).

Urine testing

A urine NAAT is designed to detect bacterial genetic material, not to provide a general health check. For men or people with a penis, UK guidance says first-void urine is more sensitive than urethral sampling and recommends holding urine for at least one hour, using the first 20 mL collected (UK SMI guidance).

Swab testing

A swab can collect material directly from the site being investigated. That may mean a vulvovaginal swab, throat swab, rectal swab, or a swab from an active lesion, depending on the suspected infection.

If your concern involves oral or anal sex, mention that when choosing a test. A genital-only kit may not include the sites that need checking. Repose Healthcare provides swab test kits for people whose testing needs call for a swab rather than urine.

Blood testing

Blood tests are commonly used for HIV and syphilis. Hepatitis B and C may be added when risk factors make them relevant. Routine screening isn't automatically a fixed panel for everyone, so selecting a broader screen should follow your exposure history and appropriate healthcare guidance.

Who Should Get Tested and When to Test After Exposure

You don't need symptoms to have a reason to test. A new partner, condomless sex, a partner's diagnosis, uncertainty about a previous partner's status, or regular screening can all justify seeking advice.

England's 2025 figures show that STI tests are frequently taken by people who feel well. At the same time, the same report recorded more than 334,000 STI diagnoses in England in 2025, even after an annual fall of 8.3% (UKHSA's 2025 STI report). No symptoms therefore shouldn't be treated as proof that no infection is present.

Match the situation to the action

• New partner: Consider testing as part of an honest conversation about sexual health, even when nobody has symptoms.
• Regular screening: People who are sexually active may choose periodic screening based on their partners, practices, and healthcare advice.
• Symptoms: Arrange prompt clinical assessment. Don't wait for a routine screening date if you have pain, sores, unusual discharge, or other concerning changes.
• Partner diagnosed: Contact a sexual health service or clinician, explain the exposure, and ask which tests and treatments are needed.
• Recent high-risk HIV exposure: Seek urgent advice if the possible exposure was within 72 hours, because post-exposure prophylaxis, or PEP, may still be an option (Leicester Sexual Health testing guidance).

Window periods change the answer

A window period is the time between possible exposure and when a test is more likely to detect an infection. Testing immediately after sex may provide an early result, but a negative result taken too soon can't always rule out infection.

For at-home testing, NHS inform advises:

• Chlamydia and gonorrhoea: Wait 2 weeks after possible exposure.
• HIV: Wait 45 days.
• Syphilis: Test at 6 weeks.
• After chlamydia or gonorrhoea treatment: Retest at 6 weeks, because a test can still appear positive even after the infection has cleared.

Example: If you had condomless sex last weekend, an immediate chlamydia or gonorrhoea self-test may be too early. Mark the two-week point for those tests, and use the 45-day HIV timing. If HIV exposure may have occurred within the last 72 hours, don't wait for a kit. Seek urgent PEP advice.

Testing guidance can vary with the type of test and your circumstances. If you have symptoms or a known exposure, a sexual health service can help you choose the safest timeline.

Accuracy Window Periods and Limitations You Should Know

A negative result means the laboratory didn't detect the target in that sample. It doesn't necessarily mean that an infection is impossible, particularly if the sample was collected too soon, from the wrong body site, or incorrectly.

Sample choice affects detection. UK guidance recommends vulvovaginal swabs for women or people with a vagina when testing for chlamydia and gonorrhoea, while first-catch urine is preferred for men or people with a penis. Following the collection instructions closely is part of test accuracy, not a minor administrative detail.

Gonorrhoea results may need confirmation

Gonorrhoea testing illustrates why laboratories use confirmation algorithms. UK guidance says that a NAAT testing pathway should achieve a minimum positive predictive value of 90%. In most cases, that requires a supplementary NAAT targeting a different nucleic-acid sequence to confirm a positive result (UK gonorrhoea detection guidance).

That doesn't mean a positive screen should be ignored. It means the result should move into the correct clinical pathway, where confirmatory testing and treatment decisions can be handled properly.

Routine screening is tailored

A “full panel” doesn't mean the same thing for every person. UK primary-care guidance describes routine screening as potentially including chlamydia, gonorrhoea, syphilis, and HIV, with hepatitis B and C added when risk factors are present (NHS Borders STI protocol).

This approach avoids two common mistakes. Ordering too little can miss an infection at an exposed site, while ordering tests that don't fit the situation can create confusion about results and follow-up. Herpes, HPV, and other conditions may require separate clinical assessment rather than being automatically added to a standard screen.

Treatment affects follow-up

After treatment, the timing of another test matters. NHS inform recommends a 6-week retest after treatment for chlamydia or gonorrhoea, because residual material can affect the result even when the infection has cleared (NHS inform's at-home STI testing guidance). Follow the advice given by the treating service, especially if symptoms continue or a partner hasn't been treated.

For a practical explanation of how timing affects kit selection, see this guide to the STI test window period.

Confidentiality Results and Next Steps After Testing

Confidentiality is a practical concern, not an afterthought. Before ordering or attending a service, check how the provider sends results, how returned samples are tracked, and whether you can speak to someone if the result needs explanation.

At-home services generally send a kit to the address supplied at checkout, and you return the sample using the packaging provided. Repose Healthcare states that samples are processed in UK-accredited laboratories and results are delivered through a secure, GDPR-compliant online dashboard. Your result should be read alongside the test type, sample site, and time since exposure.

When the result is negative

A negative result can be reassuring when the test was taken after the appropriate window period and the correct sample was provided. It doesn't protect you from a future infection, and it may not settle the question if you tested early or didn't test an exposed site.

Check the report for:

• The infections included: A negative chlamydia result says nothing about HIV or syphilis unless those were tested separately.
• The sample used: A genital sample may not assess a throat or rectal exposure.
• The collection date: Compare it with the relevant window period.
• Follow-up advice: A repeat test may be recommended after early testing or treatment.

When the result is positive

Don't panic, and don't delay contacting a qualified healthcare service. Many bacterial STIs are treatable, while infections such as HIV have effective long-term treatment. The next step depends on the infection, symptoms, pregnancy status, treatment history, and whether partners may also need testing.

Partner notification helps people who may have been exposed access care. Avoid sexual contact, or follow the specific safer-sex advice from your clinician, until you know what treatment and follow-up are required. Don't assume that a partner's lack of symptoms means they're unaffected.

Remember: An asymptomatic positive result is still a real health finding that deserves calm, prompt follow-up. In England, 70.3% of STI tests in 2025 were taken by people without symptoms, so testing people who feel well is a normal part of prevention (UKHSA's 2025 STI report).

If you develop severe pain, fever, significant genital swelling, difficulty urinating, or rapidly worsening symptoms, seek urgent medical advice rather than waiting for an online result.

Choosing the Right At Home STI Test for Your Needs

Start with four questions:

1. What happened? Consider the type of sexual contact, whether a condom was used, and whether a partner has reported an infection.
2. Where was the exposure? Genital, throat, and rectal exposure may require different samples.
3. When did it happen? Use the relevant window period instead of testing immediately and treating an early negative as final.
4. What do you need to test for? A targeted chlamydia and gonorrhoea test may suit one situation, while a broader screen may be appropriate when several infections are relevant.

At-home testing can be useful when you want a discreet route and can collect and return the sample carefully. It isn't the right substitute for urgent care, PEP advice, examination of active sores, or support with a positive result that needs treatment.

For publishers, clinics, and healthcare businesses building clearer patient education, resources on services for medspas and law firms can provide useful context on professional digital communication.

Recheck the kit's instructions before collecting your sample, confirm the return window, and keep using safer-sex practices while waiting. A clear plan is more useful than ordering the biggest panel without considering timing or exposure sites.

Repose Healthcare offers discreet at-home STI testing with clear collection instructions, prepaid return packaging, UK-accredited laboratory processing, and secure online results. Visit Repose Healthcare to choose a targeted or broader test that matches your exposure and start your testing plan with confidence.